Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-β1-dependent mechanism in vitro

American Journal of Kidney Diseases

Volumn 37, Issue 4, 2001, Pages 820-831

  Fan, Jun Ming ^a,b,c,d,e   Huang, Xiao Ru ^a,b,c,d,e   Ng, Yee Yung ^a,b,c,d,e   Nikolic Paterson, David J ^a,b,c,d,e   Mu, Wei ^a,b,c,d,e   Atkins, Robert C ^a,b,c,d,e   Lan, Hui Y ^a,d  

^a WEST CHINA UNIVERSITY OF MEDICAL SCIENCES   (China)

^b MONASH MEDICAL CENTRE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

E cadherin; Epithelial; Interleukin 1 (IL 1); Mesenchymal; Transdifferentiation; Transforming growth factor (TGF ); smooth muscle actin ( SMA)

Indexed keywords

ALPHA ACTIN; INTERLEUKIN 1; MESSENGER RNA; PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; KIDNEY FIBROSIS; KIDNEY TUBULE EPITHELIUM; MYOFIBROBLAST; NONHUMAN; PROTEIN EXPRESSION; RAT;

EID: 0035061819     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(01)80132-3     Document Type: Article

References (61)

1. Molecular insights into renal interstitial fibrosis
2. Role of myofibroblasts during normal tissue repair and excessive scarring: Interest of their assessment in nephropathies
3. 1(III) collagen expression in experimental tubulointerstitial nephritis
4. Myofibroblast-like cells produce mRNA for type I and III procollagens in chronic active hepatitis
5. Lung fibroblast alpha-smooth muscle actin expression and contractile phenotype in bleomycin-induced pulmonary fibrosis
6. Human renal cortical interstitial cells with some features of smooth muscle cells participate in tubulointerstitial and crescentic glomerular injury
7. Myofibroblasts, predictors of progression of mesangial IgA nephropathy?
8. Interstitial myofibroblasts: Predictors of progression in membranous nephropathy
9. Interstitial alpha-smooth muscle actin: A prognostic marker in membranous nephropathy
10. Myofibroblasts and the progression of diabetic nephropathy
11. Myofibroblasts and the progression of experimental glomerulonephritis
12. Interstitial myofibroblasts in experimental renal infection and scarring
13. Local macrophage and myofibroblasts proliferation in 5/6 nephrectomised rat model
14. Identification and characterization of a fibroblast marker: FSP1
15. Evidence for tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephretomized rats
16. Glomerular epithelial-myofibroblast transdifferentiation in the evolution of glomerular crescent formation
17. Early role of Fsp1 in epithelial-mesenchymal transformation
18. TGF-β regulates tubular epithelial-myofibroblast transdifferentiation in vitro
19. The role of interleukin-1 in disease
20. Fibrogenic cytokines: The role of immune mediators in the development of scar tissue
21. Effects of continuously administered murine interleukin-1 alpha: Tolerance development and granuloma formation
22. Interleukin-1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica
23. Modulation of fibroblast functions by interleukin-1: Increased steady-state accumulation of type I procollagen messenger RNAs and stimulation of other functions but not chemotaxis by human recombinant interleukin-1 alpha and beta
24. Collagen synthesis by human liver (myo)fibroblasts in culture: Evidence for a regulatory role of IL-1 beta, IL-4, TGF beta and IFN gamma
25. Effects of interleukin-1 beta on human pulpal fibroblast proliferation and collagen synthesis
26. Type VI collagen-specific messenger RNA is expressed constitutively by cultured human synovial fibroblasts and is suppressed by interleukin-1
27. IL-1 rescues scleroderma myofibroblasts from serum-starvation-induced cell death
28. Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist
29. Interleukin-1 receptor antagonist halts the progression of established crescentic glomerulonephritis in the rat
30. Interleukin-1 receptor antagonist modulates the progression of a spontaneously occurring IgA nephropathy in mice
31. Effects of transforming growth factor-beta on collagen synthesis by normal rat kidney epithelial cells
32. Evidence for C-type natriuretic peptide production in the rat kidney
33. Altered expression of transforming growth factor-alpha in hereditary rat renal cell carcinoma
34. Up-regulation of ICAM-1 and VCAM-1 expression during macrophage recruitment in lipid-induced glomerular injury in ExHC rats
35. A novel, simple, sensitive, and reliable method for multiple immunoenzyme staining. The use of microwave oven heating technique for blocking of antibody crossreactivities and retrieval of antigens
36. Development of human prostate cancer cells to neuroendocrine-like cells by interleukin-1
37. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells
38. Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines
39. Dedifferentiated chondrocytes cultured in alginate beads: Restoration of the differentiated phenotype and of the metabolic responses to interleukin-1beta
40. Interleukin-1 in renal fibrosis
41. Interleukin-1 receptor antagonist ameliorates experimental antiglomerular basement membrane antibody-associated glomerulonephritis
42. Modulation of antibody-mediated glomerular injury in vivo by IL-1ra, soluble IL-1 receptor, and soluble TNF receptor
43. Production of interleukin-1 in glomerular cell cultures from patients with rapidly progressive crescentic glomerulonephritis
44. In situ production of TNF-α, IL-1β and IL-2R in ANCA-positive glomerulonephritis
45. In situ expression of cytokines in IgA nephritis
46. Podocytes are the major source of IL-1α and IL-1β in human glomerulonephritides
47. Increased tumor necrosis factor and IL-1β gene expression in the kidneys of mice with lupus nephritis
48. Glomerular cells and macrophages in the progression of experimental focal glomerulosclerosis
49. Intrinsic renal cells are the major source of interleukin-1β synthesis in normal and diseased rat kidney
50. Cytokines in human renal interstitial fibrosis. I. Interleukin-1 is a paracrine growth factor for cultured fibrosis-derived kidney fibroblasts
51. Modulation of collagen synthesis in human glomerular epithelial cells by interleukin-1
52. TGF-beta in kidney fibrosis: A target for gene therapy
53. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney
54. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1
55. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease
56. Gene therapy by transforming growth factor-beta receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis
57. Epithelial-myofibroblast transdifferentiation (EMT) in glomerular crescent progression and tubulointerstitial (TI) fibrosis in human glomerulonephritis
58. Dissociation of Madin-Darby canine kidney epithelial cells by the monoclonal antibody anti-Arc-1: Mechanistic aspects and identification of the antigen as a component related to uvomorulin
59. Dissecting tumor cells invasion: Epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion
60. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role
61. E-Cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium